These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 5067202

  • 21. Clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in painful osteoarticular conditions.
    Pasotti C, Barbieri C, Buniva G, Chierichetti S.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:262-5. PubMed ID: 4553234
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 6. Activity on polyarthritis induced in rats by Freund's adjuvant.
    Lumachi B.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:204+. PubMed ID: 5067194
    [No Abstract] [Full Text] [Related]

  • 23. Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Dotti F, Ongari R, Carazzi R, Chierichetti S.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:265-8. PubMed ID: 4553235
    [No Abstract] [Full Text] [Related]

  • 24. Controlled clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) and oxyphenbutazone in thrombophlebitis.
    Seghezzi R, Borri P, Chierichetti S, Ferrari P.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:272-4. PubMed ID: 4553236
    [No Abstract] [Full Text] [Related]

  • 25. [Experimental study of the pharmacodynamic effects of a camphosulfonic derivative of nicotinoyl dimethyl pyrazolone].
    La Barre J, Alechinsky A.
    Bull Acad R Med Belg; 1968 Jan; 8(5):469-88. PubMed ID: 5312096
    [No Abstract] [Full Text] [Related]

  • 26. [Contribution to the pharmacodynamic study of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidinopiperazine].
    La Barre J, Derouaux G, Oleffe-Koopmansch S.
    Arch Int Pharmacodyn Ther; 1966 Apr; 160(2):265-83. PubMed ID: 5954030
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedion (DA 2370). 4. Analgesic activity on bradykinin evoked pain in rats.
    Lumachi.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:201-2. PubMed ID: 5067192
    [No Abstract] [Full Text] [Related]

  • 28. Physico-chemical and analytical studies on 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Perego R, Gallazzi A, Vanoni PC, Lucarella I.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:177+. PubMed ID: 5067189
    [No Abstract] [Full Text] [Related]

  • 29. Absorption and distribution of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA2370) in the rat.
    Coppi G, Vidi A, Gallazzi A, Perego R.
    Arzneimittelforschung; 1974 May; 24(5):801-2. PubMed ID: 4408147
    [No Abstract] [Full Text] [Related]

  • 30. 1-Acetyl-5-aryl-3-[(substituted indole-3-yl-methylene-amino) phenyl]-4-pyrazolines as anti-inflammatory agent.
    Kumar A, Kumar A, Saxena AK, Shanker K.
    Pharmazie; 1988 Jan; 43(1):45-6. PubMed ID: 3375301
    [No Abstract] [Full Text] [Related]

  • 31. [Differentiation of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine (phenylbutazone) and 3,5-dioxo-1,2-diphenyl-4-prenyl-pyrazolidine (prenazone) using reaction chromatography].
    schütz C, Schütz H.
    Arzneimittelforschung; 1973 Mar; 23(3):428-31. PubMed ID: 4740130
    [No Abstract] [Full Text] [Related]

  • 32. [Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370].
    Scanni A, Ferrari P.
    Minerva Med; 1973 Oct 10; 64(71):3718-24. PubMed ID: 4588363
    [No Abstract] [Full Text] [Related]

  • 33. [Pharmacological properties of trimetazone--a new pyrazolidine derivative. II. Other pharmacological properties].
    Muratová J, Záhor Z.
    Cesk Farm; 1971 Apr 10; 20(3):99-102. PubMed ID: 5574092
    [No Abstract] [Full Text] [Related]

  • 34. [Physiological activity and some physico-chemical properties of acyl derivatives of pyrazolone].
    Saratikov AS, Lomov NI, Syrneva NV, Chernova NA, Prushchep TP, Lavrent'eva LN, Shchipkova LG.
    Farmakol Toksikol; 1968 Apr 10; 31(4):437-41. PubMed ID: 5698134
    [No Abstract] [Full Text] [Related]

  • 35. Effects of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370, fenilprenazone) on lysosomes.
    Coppi G, Bonardi G, Vidi A.
    Biochem Pharmacol; 1973 May 15; 22(10):1237-9. PubMed ID: 4707605
    [No Abstract] [Full Text] [Related]

  • 36. Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.
    Cepeláková H, Roubal Z, Grimová J, Dlabac A, Cepelák V.
    Acta Univ Carol Med Monogr; 1972 May 15; 52():55-60. PubMed ID: 4669827
    [No Abstract] [Full Text] [Related]

  • 37. [Pharmacological properties of a combination of the antirheumatic drug Benetazone (trimetazone) and the analgesic drug dextropropoxyphene].
    Grimová J, Nĕmecek O, Rádek O, Volková Z.
    Cesk Farm; 1974 Feb 15; 23(1):28-33. PubMed ID: 4458971
    [No Abstract] [Full Text] [Related]

  • 38. [1st experiences in urology with a new non-steroid anti-inflammatory agent].
    Rocca Rossetti S, Oggianu F, Chierichetti S.
    Minerva Urol; 1973 Feb 15; 25(6):276-84. PubMed ID: 4781118
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacological investigations of benzothiazoline derivatives.
    Takashima T, Kado Y, Kumada S.
    Arzneimittelforschung; 1972 Apr 15; 22(4):711-5. PubMed ID: 5068252
    [No Abstract] [Full Text] [Related]

  • 40. Some novel pyrazolone derivatives as anti-inflammatory agents.
    Farghaly AM, El-Khwass SM, Khalil MA, Sharabi FM, Daabees TT.
    Pharmazie; 1981 Apr 15; 36(2):93-5. PubMed ID: 7232494
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.